国际子宫移植登记系统(IRUTx)的建立:前景与挑战
子宫移植(UTx)是实验性血管复合同种异体移植,为绝对子宫因素不孕女性提供孕育机会,全球已实施≥70例。随着病例增加,数据分散且多未发表,学界呼吁建立国际子宫移植登记系统(IRUTx)。本文探讨IRUTx对利益相关方的潜在益处,以及数据集设计、知情同意、隐私、研究者合规与治理方面的法律伦理挑战。
要点
- 全球UTx已实施≥70例,数据分散且多未发表,亟需国际登记系统整合信息。
- IRUTx可辅助UTx的发展、实践与监管,但需解决数据集设计、知情同意与隐私等伦理法律问题。
- 建立IRUTx需平衡数据共享益处与研究者合规及治理挑战。
核心结论
- 建立国际子宫移植登记系统(IRUTx)对UTx的发展、实践和监管具有潜在价值,但需应对法律与伦理挑战。
研究设计与样本
- 本文为综述性文章,分析UTx数据现状并探讨IRUTx建立的益处与挑战,未报告系统检索范围。
主要发现
- 全球UTx手术例数已≥70例,但数据仍多未发表或分散,追踪病例与结局存在困难。
- 学界日益呼吁尽快创建、实施和管理国际子宫移植登记系统(IRUTx)。
临床怎么用
- 临床开展UTx时需关注数据上报与登记,参与IRUTx有助于积累证据并推动领域规范发展。
局限性
- 本文为观点与指导性文章,未提供具体登记系统设计方案或实证数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Uterus Transplantation (UTx) is an experimental vascular composite allograft designed to provide women with absolute uterine factor infertility with the opportunity to gestate and give birth to their future offspring. The number of UTx procedures performed worldwide now stands at ≥70 and as the number of cases performed increases so too does the volume of potential data that may be gathered to inform the development, practice and regulation of UTx. Given the value of this data, and the challenges associated with keeping track of cases and outcomes where data remains unpublished and/or scattered, scientists and academics conducting research into UTx have increasingly called for the swift creation, implementation and management of an international registry for Uterus Transplantation (IRUTx). This article explores and provides practical guidance regarding the potential benefits the IRUTx may provide to stakeholders, as well as the legal and ethical challenges that its creation may pose in terms of dataset design, consent, privacy, researcher compliance and governance.
引用
- Hammond-Browning N, Williams NJ. Developing an International Registry for Uterus Transplantation (IRUTx): Promises and Challenges. Hum Reprod. 2020. PMID: 33326998. doi:10.1093/humrep/deaa207
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。